Reed Elsevier (LON: REL)‘s stock had its “buy” rating reaffirmed by Jefferies Group in a research note issued on Tuesday. They currently have a $12.03 (760 GBX) price target on the stock.

Other equities research analysts have also recently issued reports about the stock. Analysts at Exane BNP Paribas reiterated an “outperform” rating on shares of Reed Elsevier in a research note to investors on Wednesday, January 16th. They now have a $12.05 price target on the stock. Separately, analysts at Goldman Sachs reiterated a “neutral/neutral” rating on shares of Reed Elsevier in a research note to investors on Wednesday, January 9th. They now have a $11.24 price target on the stock. Finally, analysts at JPMorgan Chase reiterated an “overweight” rating on shares of Reed Elsevier in a research note to investors on Friday, November 30th. They now have a $10.99 price target on the stock.

Reed Elsevier opened at 687.646 on Tuesday. Reed Elsevier has a 1-year low of GBX 466.10 and a 1-year high of GBX 691.50. The stock’s 50-day moving average is currently GBX 599.8. The company’s market cap is £8.280 billion.

Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.